untitledMyeloproliferative neoplasms treated with hydroxyurea, pegylated interferon alpha-2A or ruxolitinib: clinicohematologic responses, quality-of-life changes and safety

untitledMyeloproliferative neoplasms treated with hydroxyurea, pegylated interferon alpha-2A or ruxolitinib clinicohematologic responses, quality-of-life changes and safety

untitledPulmonary veno-occlusive disease in myeloproliferative disorder E. Willems*, J-L. Canivet#, B. Ghaye", L. de Leval+, M. Radermecker1, J-C. Preiser# and Y. Beguin*

20200129x_thesis_final_KubesovaDEPARTMENT OF INTERNAL MEDICINE – HEMATOLOGY AND ONCOLOGY FACULTY HOSPITAL BRNO Ph.D. thesis in the field of Experimental Oncology and

Summary. A comparative immunohistochemical and morphometric study was performed on megakaryocytes in 20 patients presenting with initial-early stage chronic idiopathic myelofibrosis